Compounds > 2,6-dimethyl-4-(2'-nitrosophenyl)-3,5-pyridinedicarboxylic acid dimethyl ester
Page last updated: 2024-09-03

2,6-dimethyl-4-(2'-nitrosophenyl)-3,5-pyridinedicarboxylic acid dimethyl ester and Cardiovascular Diseases

2,6-dimethyl-4-(2'-nitrosophenyl)-3,5-pyridinedicarboxylic acid dimethyl ester has been researched along with Cardiovascular Diseases in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ikeda, Y; Imanishi, M; Ishizawa, K; Ishizawa, Y; Kihira, Y; Sakurada, T; Tamaki, T; Tsuchiya, K; Yamano, N1

Reviews

1 review(s) available for 2,6-dimethyl-4-(2'-nitrosophenyl)-3,5-pyridinedicarboxylic acid dimethyl ester and Cardiovascular Diseases

ArticleYear
[Drug development for cardiorenal disease based on oxidative stress control].
    Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan, 2014, Volume: 134, Issue:6

    Topics: Animals; Cardiovascular Diseases; Humans; Nifedipine; Nitric Oxide; Nitroso Compounds; Oxidative Stress; Reactive Oxygen Species; Renal Insufficiency, Chronic

2014